BioSpace News Archive

-Generated net proceeds of $48 million from equity offering and disposition of Aytu shares to support pipeline advancement -Enrolled first patient in CERC-002 (anti-LIGHT mAb) clinical trial for the prevention of COVID-19 induced ARDS ROCKVILLE, Md. and CHESTERBROOK, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ : CERC), a leading biopharmaceutical company focused on development and commercialization of treatments for rare pediatric and orphan diseases, today announced recent

RNA-based gene silencing has been heralded a novel means for drug target identification and validation.

The global osteosynthesis devices market has been anticipated in a report by Transparency Market Research to demonstrate a highly consolidated nature owing to a large string of mergers and acquisitions.

According to the report, the global organ transplant rejection medications market was valued at US$ 4.7 Bn in 2018 and is projected to expand at a CAGR of ~3% from 2019 to 2027.

With a large pool of vendors of acute care needleless connectors across the world, the global acute care needleless connectors market are displaying a highly competitive business landscape, states a new study by Transparency Market Research.

Avacta appoints BBI Solutions as manufacturing partner for the rapid SARS-CoV-2 antigen test being developed with Cytiva

The demand within the global actinic keratosis treatment market is set to trace an ascending trajectory in the years to follow.

Collaboration will include data sharing, R&D and an upgrade of RadNet’s fleet of Hologic mammography systems to state-of-the-art imaging technology

BD, a leading global medical technology company, reported quarterly revenues of $3.855 billion for the third fiscal quarter ended June 30, 2020.

Curated Menu of Off-the-Shelf RNAscope Probes Provide Seamless Molecularly-Guided Region of Interest Selection for Use With the New NGS-Enabled Cancer Transcriptome Atlas